These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 8710906)
1. Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population. FitzGerald MG; Harkin DP; Silva-Arrieta S; MacDonald DJ; Lucchina LC; Unsal H; O'Neill E; Koh J; Finkelstein DM; Isselbacher KJ; Sober AJ; Haber DA Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8541-5. PubMed ID: 8710906 [TBL] [Abstract][Full Text] [Related]
2. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes. Soufir N; Bressac-de Paillerets B; Desjardins L; Lévy C; Bombled J; Gorin I; Schlienger P; Stoppa-Lyonnet D Br J Cancer; 2000 Feb; 82(4):818-22. PubMed ID: 10732752 [TBL] [Abstract][Full Text] [Related]
3. Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma. Tachibana I; Smith JS; Sato K; Hosek SM; Kimmel DW; Jenkins RB Am J Med Genet; 2000 May; 92(2):136-41. PubMed ID: 10797439 [TBL] [Abstract][Full Text] [Related]
4. Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma. Gao L; Liu L; van Meyel D; Cairncross G; Forsyth P; Kimmel D; Jenkins RB; Lassam NJ; Hogg D Clin Cancer Res; 1997 Jun; 3(6):977-81. PubMed ID: 9815774 [TBL] [Abstract][Full Text] [Related]
5. p16/CDKN2 and CDK4 gene mutations in sporadic melanoma development and progression. Piccinin S; Doglioni C; Maestro R; Vukosavljevic T; Gasparotto D; D'Orazi C; Boiocchi M Int J Cancer; 1997 Feb; 74(1):26-30. PubMed ID: 9036865 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group. Soufir N; Avril MF; Chompret A; Demenais F; Bombled J; Spatz A; Stoppa-Lyonnet D; Bénard J; Bressac-de Paillerets B Hum Mol Genet; 1998 Feb; 7(2):209-16. PubMed ID: 9425228 [TBL] [Abstract][Full Text] [Related]
7. Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas. Maelandsmo GM; Flørenes VA; Hovig E; Oyjord T; Engebraaten O; Holm R; Børresen AL; Fodstad O Br J Cancer; 1996 Apr; 73(8):909-16. PubMed ID: 8611425 [TBL] [Abstract][Full Text] [Related]
8. Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: a clinic-based population study. Platz A; Hansson J; Ringborg U Int J Cancer; 1998 Sep; 78(1):13-5. PubMed ID: 9724087 [TBL] [Abstract][Full Text] [Related]
9. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas. Hashemi J; Platz A; Ueno T; Stierner U; Ringborg U; Hansson J Cancer Res; 2000 Dec; 60(24):6864-7. PubMed ID: 11156381 [TBL] [Abstract][Full Text] [Related]
10. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation. Della Torre G; Pasini B; Frigerio S; Donghi R; Rovini D; Delia D; Peters G; Huot TJ; Bianchi-Scarra G; Lantieri F; Rodolfo M; Parmiani G; Pierotti MA Br J Cancer; 2001 Sep; 85(6):836-44. PubMed ID: 11556834 [TBL] [Abstract][Full Text] [Related]
11. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104 [TBL] [Abstract][Full Text] [Related]
13. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Zuo L; Weger J; Yang Q; Goldstein AM; Tucker MA; Walker GJ; Hayward N; Dracopoli NC Nat Genet; 1996 Jan; 12(1):97-9. PubMed ID: 8528263 [No Abstract] [Full Text] [Related]
14. Affected members of melanoma-prone families with linkage to 9p21 but lacking mutations in CDKN2A do not harbor mutations in the coding regions of either CDKN2B or p19ARF. Liu L; Goldstein AM; Tucker MA; Brill H; Gruis NA; Hogg D; Lassam NJ Genes Chromosomes Cancer; 1997 May; 19(1):52-4. PubMed ID: 9135995 [TBL] [Abstract][Full Text] [Related]
15. Lack of germline CDK6 mutations in familial melanoma. Shennan MG; Badin AC; Walsh S; Summers A; From L; McKenzie M; Goldstein AM; Tucker MA; Hogg D; Lassam N Oncogene; 2000 Mar; 19(14):1849-52. PubMed ID: 10777219 [TBL] [Abstract][Full Text] [Related]
16. Genes involved in melanoma: an overview of INK4a and other loci. Castellano M; Parmiani G Melanoma Res; 1999 Oct; 9(5):421-32. PubMed ID: 10596908 [TBL] [Abstract][Full Text] [Related]
17. Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma. Tsao H; Zhang X; Kwitkiwski K; Finkelstein DM; Sober AJ; Haluska FG Arch Dermatol; 2000 Sep; 136(9):1118-22. PubMed ID: 10987867 [TBL] [Abstract][Full Text] [Related]
18. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma. Sonoda Y; Yoshimoto T; Sekiya T Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535 [TBL] [Abstract][Full Text] [Related]
19. p16 proteins from melanoma-prone families are deficient in binding to Cdk4. Reymond A; Brent R Oncogene; 1995 Sep; 11(6):1173-8. PubMed ID: 7566978 [TBL] [Abstract][Full Text] [Related]